February 10, 2022
Authored and Edited by Angeline L. Premraj; Kara A. Specht; Esther H. Lim; Elizabeth D. Ferrill
In Qualcomm Incorporated v. Apple Inc., Nos. 20-1558, 20-1559 (Fed. Cir. Feb. 1, 2022), the Federal Circuit vacated and remanded decisions by the Patent Trial and Appeal Board (“the Board”) finding several claims of a Qualcomm’s patent unpatentable under 35 U.S.C. § 103.
The Federal Circuit held that the Board erroneously considered applicant admitted prior art (“AAPA”) to be “prior art consisting of patents or printed publications” as a “basis” in its inter partes review of the patent under 35 U.S.C. § 311(b). Specifically, the Federal Circuit relied on the legislative history of § 311(b), which indicated that to form the “basis” of a ground of inter partes review, the patent or printed publication must itself be a document that is prior art to the challenged patent. In this case, the Federal Circuit found that the AAPA could not be the “basis” because the AAPA is not a document separate from the challenged patent. However, the Court did not foreclose the consideration of AAPA entirely. While not as a “basis,” the Court noted, based on Federal Circuit precedent and legislative intent, that the AAPA may still be considered to some extent in an inter partes review.
Patent Trial and Appeal Board (PTAB), Obviousness (35 USC § 103), United States Court of Appeals for the Federal Circuit (CAFC)
Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.